March 16th, 2023
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023
IPA’s Project revenue increased by 16.7% compared to the prior year, driven by the growth of the company's proprietary B cell Select® platform and protein manufacturing services. Talem Therapeutics has announced a collaboration with Libera Bio to...